✦ LIBER ✦

Estimating the risks and benefits of tamoxifen for breast cancer chemoprevention in Korea

✍ Scribed by M. Chang

Book ID: 119597897
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 57 KB
Volume: 6
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(08)70403-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast carcinoma chemoprevention in the

Breast carcinoma chemoprevention in the community setting : Estimating risks and benefits

✍ Abenaa M. Brewster; Dana K. Christo; Hong Lai; Kathy Helzlsouer 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

## Abstract ## BACKGROUND The United States Preventive Services Task Force recommends that women who are at both high risk for breast carcinoma and low risk for adverse events should receive counseling regarding tamoxifen for chemoprevention. Estimates of the risks and benefits of tamoxifen based

Chemoprevention of breast cancer by tamo

Chemoprevention of breast cancer by tamoxifen: risks and opportunities

✍ Lewis L. Smith; Ian N.H. White 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 583 KB

Use of tamoxifen and raloxifene for brea

Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010

✍ Erika A. Waters, Timothy S. McNeel, Worta McCaskill Stevens, Andrew N. Freedman 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 166 KB

Breast-cancer prevention: is the risk-be

Breast-cancer prevention: is the risk-benefit ratio in favour of tamoxifen?

✍ Jonas Bergh 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 85 KB

The benefits and costs of tamoxifen for

The benefits and costs of tamoxifen for breast cancer prevention

✍ Simon D. Eckermann; Andrew J. Martin; Martin R. Stockier; R. John Simes 📂 Article 📅 2003 🏛 Public Health Association of Australia 🌐 English ⚖ 56 KB

S20. Tamoxifen or Raloxifen for chemopre

S20. Tamoxifen or Raloxifen for chemoprevention of breast cancer in high risk women: The NSABP-experience

✍ D.L. Wickerham 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 34 KB